Skip to main content
  • About Us
  • News
  • Careers
  • Authorized Partners
  • Products
  • Conditions
  • Education & Events
  • Careers
  • News

FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY

Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta

GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta

Gore Acquires Pipeline Medical Technologies, Inc.

Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies

Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease

Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies

Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Antegrade iteration accepted into study – advancing this branched, all-in-one system

One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions

Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis

GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study

Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE® VIABAHN® Endoprosthesis

Innovative treatment offers long-term solution for ISR

Pagination

  • Load more

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.

  • Cookie Settings
  • Legal Information
  • Privacy Notice
  • Regulatory Information
  • Trademarks
  • Contact Us
  • Newsletter
  • Modern Slavery Statement
  • gore.com

Copyright © 2002-2025 | W. L. Gore & Associates, Inc. | Products listed may not be available in all markets.